A Mixture of U.S. Food and Drug Administration–Approved Monoaminergic Drugs Protects the Retina From Light Damage in Diverse Models of Night Blindness

PURPOSE: The purpose of this study was to test the extent of light damage in different models of night blindness and apply these paradigms in testing the therapeutic efficacy of combination therapy by drugs acting on the G(i), G(s), and G(q) protein-coupled receptors. METHODS: Acute bright light exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Leinonen, Henri, Choi, Elliot H., Gardella, Anthony, Kefalov, Vladimir J., Palczewski, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2019
Materias:
Physiology and Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736410/
https://www.ncbi.nlm.nih.gov/pubmed/30947334
http://dx.doi.org/10.1167/iovs.19-26560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736410/
https://www.ncbi.nlm.nih.gov/pubmed/30947334
http://dx.doi.org/10.1167/iovs.19-26560

Ejemplares similares